MOG-IgG in primary and secondary chronic progressive multiple sclerosis: a multicenter study of 200 patients and review of the literature.

MLA

Jarius, S., et al. “MOG-IgG in Primary and Secondary Chronic Progressive Multiple Sclerosis: A Multicenter Study of 200 Patients and Review of the Literature.” Journal of Neuroinflammation, vol. 15, Mar. 2018, p. 1. EBSCOhost, https://doi.org/10.1186/s12974-018-1108-6.

APA

Jarius, S., Ruprecht, K., Stellmann, J. P., Huss, A., Ayzenberg, I., Willing, A., Trebst, C., Pawlitzki, M., Abdelhak, A., Grüter, T., Leypoldt, F., Haas, J., Kleiter, I., Tumani, H., Fechner, K., Reindl, M., Paul, F., Wildemann, B., & Grüter, T. (2018). MOG-IgG in primary and secondary chronic progressive multiple sclerosis: a multicenter study of 200 patients and review of the literature. Journal of Neuroinflammation, 15, 1. https://doi.org/10.1186/s12974-018-1108-6

Chicago

Jarius, S., K. Ruprecht, J. P. Stellmann, A. Huss, I. Ayzenberg, A. Willing, C. Trebst, et al. 2018. “MOG-IgG in Primary and Secondary Chronic Progressive Multiple Sclerosis: A Multicenter Study of 200 Patients and Review of the Literature.” Journal of Neuroinflammation 15 (March): 1. doi:10.1186/s12974-018-1108-6.